Entities / Company
Sun Pharmaceutical.
Indian multinational pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 40
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ days-
Sun Pharmaceutical and Larsen & Toubro are featured in the top three holdings of two specific dividend yield funds, as of July 9, 2026.Some support1 report
-
Infosys declines ahead of IT earnings season, while JPMorgan's sector upgrade affects Sun Pharma amidst West Asia tension.Some support1 report
-
On June 23, 2026, IT stocks declined during a market selloff, while Sun Pharmaceutical bucked the trend.Some support1 report
-
Fortress subsidiary Checkpoint Therapeutics was acquired by Sun Pharmaceutical.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Sun Pharmaceutical this week
News at the entities that move Sun Pharmaceutical most-
Donald Trump TransactionalCNN reports on Trump's political targeting, James Comey's indictment over an Instagram post, and Letitia James's second home.Moves Sun Pharmaceutical
-
S&P Global Ratings TransactionalUzbekneftegaz, Uzbekistan's state-owned oil and gas company, is seeking higher credit ratings from S&P Global Ratings and Fitch Ratings.Moves Sun Pharmaceutical
-
Organon & Co. TransactionalMarketBeat provided analyst recommendations and compared Organon & Co. and Xeris Biopharma.Moves Sun Pharmaceutical
-
Infosys Mentioned togetherLow valuations are attracting investor attention to Wipro, Infosys, and Tata Consultancy Services.Moves Sun Pharmaceutical
Connections
The 5 strongest of 40, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Fortress Biotech Structural
Fortress Biotech's subsidiary, Checkpoint Therapeutics, was acquired by Sun Pharmaceutical, establishing a structural relationship.
-
Organon & Co. Transactional
Sun Pharmaceutical has proposed an $11.75 billion acquisition bid for Organon & Co.
-
Donald Trump Transactional
Donald Trump secured and announced drug-pricing agreements with Sun Pharmaceutical.
-
S&P Global Ratings Transactional
S&P Global Ratings formally assessed Sun Pharmaceutical with a BBB+ long-term issuer credit rating.
-
Infosys Mentioned together
The companies were mentioned together in a market analysis comparing the performance trends of the IT and pharmaceutical sectors.